Amyloid-beta
Intervention1 paper
C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.
Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.
Funder: National Institute on Aging
Funding
National Institute on AgingUS$2m4 grants since 2023
National Institute on AgingIcahn School of Medicine at Mount SinaiUS$746.1k2026–2031
National Institute on AgingUniversity of UtahUS$308k2026–2028
National Institute on AgingMassachusetts General HospitalUS$128.5k2023–2028
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models
National Institute on AgingMassachusetts General HospitalUS$825.3k2024–2029